Other examples of successful drugs targeting genes that arise (with small effect sizes) in GWAS include PCSK9 for LDL cholesterol [33], and PPARG and KCNJ11 for type 2 diabetes [18]. The gene discussed is PPARG; the disease is type 2 diabetes mellitus.